Wirth is the CEO of Amida Care. Crowley is the director of the O’Neill Institute’s Center for HIV and Infectious Disease Policy at Georgetown Law. In June, a clinical trial showed that a twice-yearly ...

Add Yahoo as a preferred source to see more of our stories on Google. HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays ...

A little specificity would go a long way in the recommendations of the US Preventive Services Task Force (USPSTF)—that is, if we want health insurance companies to pay for lifesaving HIV prevention ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Alexis Perkins thought her OB-GYN's ...

HIV prevention doesn’t have to be scary, confusing, or even expensive. Thanks to Mistr, a gay-owned and operated online platform, protecting yourself just got a whole lot easier! Mistr works with real ...

A bill moving through the Georgia General Assembly could change how people in the state start HIV prevention medication. Senate Bill 195 would allow trained pharmacists to prescribe PrEP, a daily ...

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these celebrations were tempered by insurers’ reluctance to cover its ...